GlassScriptPhysician profile
Tamara S Loving
NPI 1144280777
$1,095.32
in general payments reported to CMS, 2019-2025
17 companies · $239 in 2025
The $239 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $50.92 · 2022: $32.41 · 2023: $249 · 2024: $258 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $245.60 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $144.62 | 2019-2025 | Doc Band |
| Kaleo, INC. | $108.52 | 2019-2023 | Auvi-Q |
| Pfizer INC. | $100.20 | 2020-2025 | |
| Glaxosmithkline, LLC. | $83.18 | 2019-2025 | Bexsero, Pediarix |
| Alk-Abello, INC | $63.21 | 2023-2025 | Grastek, Odactra, Neffy |
| Ironshore Pharmaceuticals INC. | $58.79 | 2019-2020 | |
| Sanofi Pasteur INC. | $46.73 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $40.56 | 2025 | Qelbree |
| Verrica Pharmaceuticals INC. | $40.17 | 2024 | Ycanth |
| Astrazeneca Pharmaceuticals LP | $37.91 | 2022-2024 | Flumist Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $26.99 | 2025 | Neffy |
| Corium, LLC | $25.34 | 2024 | Azstarys |
| Sobi, INC | $24.31 | 2023 | |
| Collegium Pharmaceutical, INC. | $19.45 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.12 | 2019 | |
| Aytu Biopharma, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Loving listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.